Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Contraception|May 22, 2002
Recent advances in hormonal male contraceptionM C Meriggiola, A Costantino, S Cerpolini
Minerva Ginecologica|June 20, 2007
Current status and future perspectives in male contraceptionA Costantino, S Cerpolini, A M Perrone, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal menM C Meriggiola, A Costantino, S Cerpolini, et al.
Human Reproduction (Oxford, England)|July 1, 1998
Low dose of cyproterone acetate and testosterone enanthate for contraception in menM C Meriggiola, W J Bremner, A Costantino, et al.
Fertility and Sterility|December 9, 1997
An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in menM C Meriggiola, W J Bremner, A Costantino, et al.
International Journal of Impotence Research|June 29, 2012
Androgen receptor expression in the human vagina under different physiological and treatment conditionsM Baldassarre, A M Perrone, F A Giannone, et al.
Journal of Endocrinological Investigation|June 15, 2005
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight menA Gambineri, U Pagotto, R De Lasio, et al.
International Journal of Andrology|October 1, 1995
Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy menM C Meriggiola, S Marcovina, C A Paulsen, et al.
Pageof 13